IL2 and myeloid sarcoma: In contrast, a recent prospective case control study showed that the levels of pro-inflammatory cytokines such as IL-1, IL-2, IL-6, IL-17, IL-22, TNF-α, and IFN-γ were significantly increased in the MS group when compared to the MS/cannabis and control groups.